Related references
Note: Only part of the references are listed.Allosteric binding on nuclear receptors: Insights on screening of non-competitive endocrine-disrupting chemicals
Chi Zhang et al.
ENVIRONMENT INTERNATIONAL (2022)
Current androgen receptor antagonists under investigation for resistant prostate cancer
Maria Concetta Nigro et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2022)
Darolutamide as a Second-Generation Androgen Receptor Inhibitor in the Treatment of Prostate Cancer
Ali Abbasi et al.
CURRENT MOLECULAR MEDICINE (2021)
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
Norman J. Maitland
CANCERS (2021)
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor
Mariia Radaeva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani et al.
CANCERS (2021)
Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim et al.
BIOMOLECULES (2021)
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
Fuqiang Ban et al.
CANCERS (2021)
Advances in the computational development of androgen receptor antagonists
Xueping Hu et al.
DRUG DISCOVERY TODAY (2020)
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules
Katarina Roos et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
Androgen receptor plasticity and its implications for prostate cancer therapy
Oliver Snow et al.
CANCER TREATMENT REVIEWS (2019)
Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor
Ettayapuram Ramaprasad Azhagiya Singam et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2019)
Role of Androgen Receptor in Prostate Cancer: A Review
Kazutoshi Fujita et al.
WORLD JOURNAL OF MENS HEALTH (2019)
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
Kush Dalal et al.
CANCER LETTERS (2018)
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions
Kush Dalal et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl) benzonitrile derivatives
Moriteru Asano et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling
Mojie Duan et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation
Hongli Liu et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2016)
Targeting the adaptive molecular landscape of castration-resistant prostate cancer
Alexander W. Wyatt et al.
EMBO MOLECULAR MEDICINE (2015)
Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations
Hongli Liu et al.
MOLECULAR BIOSYSTEMS (2015)
Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
Ravi S. N. Munuganti et al.
CHEMISTRY & BIOLOGY (2014)
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif
Katja Jehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
Huifang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)
Fuqiang Ban et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens
Fred Saad et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Agents That Target Androgen Synthesis in Castration-Resistant Prostate Cancer
Roberta Ferraldeschi et al.
CANCER JOURNAL (2013)
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
Jean Hoffman-Censits et al.
CLINICAL CANCER RESEARCH (2013)
Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
Nada Lallous et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives
Ravi Shashi Nayana Munuganti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors
Laura Caboni et al.
MEDICINAL RESEARCH REVIEWS (2013)
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer
Michael D. Nyquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Discovery of Diarylhydantoins as New Selective Androgen Receptor Modulators
Francois Nique et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
Zhiyong Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
Peter Axerio-Cilies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening
Nathan A. Lack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Pengxiang Huang et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens
Jinming Zhou et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators
Casey E. Bohl et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Mass spectrometry of hydantoin-derived selective androgen receptor modulators
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations
William H. Bisson et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Design of selective nuclear receptor modulators: RAR and RXR as a case study
Angel R. de Lera et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells
Peyman Tavassoli et al.
PROSTATE (2007)
Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226
Feng Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models
Junmei Wang et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2006)
Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity
KP De Jesus-Tran et al.
PROTEIN SCIENCE (2006)
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor
CE Bohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
CE Bohl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists
ME Salvati et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Share Paper
